Piper Sandler Expands Equity Research with the Hiring of Jason Bednar

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank and institutional securities firm, is pleased to announce the addition of senior research analyst, Jason Bednar. He will cover the medical technology sector and will be based in the firm’s Milwaukee office.

Prior to joining Piper Sandler, Bednar was a senior research associate and vice president at Robert W. Baird & Co. where he covered the medical technology sector.

Bednar is joining a team of 12 analysts covering 227 stocks spanning across the healthcare sector – specialty pharmaceuticals, medical technology, biotechnology, hospitals, managed care, distributors, medical technology and devices, medical diagnostics, life science tools, and healthcare services information technology.

“We are excited to welcome Jason and his 12 years of equity research experience to our MedTech research group. We aim to offer our clients the broadest and deepest research footprint in the MedTech sector,” said Michael Cox, director of equity research at Piper Sandler.

Bednar holds a Master of Business Administration degree from the University of Chicago Booth of Management and a bachelor of science in finance from Marquette University.

ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through separate investment advisory affiliates.

©2020. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036